SCHEMBL6582997

SCHEMBL6582997

COc1ccc(-c2nc(-c3cccc(C=O)c3)nn2C(C)C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.43
NR1H3 Q13133 2/20 0.43
TDP1 Q9NUW8 3/20 0.42
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
ADORA3 P0DMS8 1/20 0.38
ADORA1 P30542 1/20 0.38
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CYP2A6 P11509 1/20 0.37
TP53 P04637 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
EGFR P00533 1/20 0.37
CCNB2 O95067 1/20 0.37
CDK1 P06493 1/20 0.37
CCNB1 P14635 1/20 0.37
CDK5 Q00535 1/20 0.37
CDK5R1 Q15078 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6582814 0.95 NPC1 (0.40) NR1H2NR1H3TDP1NPC1RAB9A
SCHEMBL6578551 0.85 NPC1 (0.39) NR1H2NR1H3TDP1NPC1RAB9A
SCHEMBL6578166 0.85 HSD17B2 (0.51) NR1H2NR1H3TDP1NPC1RAB9A
SCHEMBL17280132 0.83 TDP1 (0.47) NR1H2NR1H3TDP1NPC1RAB9A
SCHEMBL6578621 0.82 NR1H2 (0.43) NR1H2NR1H3TDP1NPC1RAB9A
SCHEMBL6584155 0.82 NR1H3 (0.51) NR1H2NR1H3TDP1NPC1RAB9A
SCHEMBL6580402 0.81 NR1H3 (0.47) NR1H2NR1H3TDP1NPC1RAB9A
SCHEMBL6580839 0.80 KDM4C (0.49) NR1H2NR1H3TDP1NPC1RAB9A
SCHEMBL6578548 0.80 NR1H3 (0.64) NR1H2NR1H3TDP1NPC1RAB9A
SCHEMBL6584100 0.79 NR1H2 (0.48) NR1H2NR1H3TDP1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1070708-B1 Triazole derivatives HOFFMANN LA ROCHE (CH) 2004-01-14 EP disclosed
US-6265426-B1 CENTRAL NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. 2001-07-24 US disclosed
EP-1070708-A1 Triazole and imidazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 2001-01-24 EP disclosed